Global Vaginal Fungi Infections Treatment Market to Surpass US$ 1,420.1 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global vaginal fungi infections treatment market is estimated to be valued at US$ 987.2 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Vaginal fungi infections treatment Market:

Key trends in the vaginal fungi infection treatment market include rising incidence of vaginal fungi infection and product approvals and launches for treatment of vaginal fungi infection.

Market players are actively focusing product launches and approvals for vaginal fungi infections treatment for cost effective and quality treatment. Moreover, the players are committed to offer new and improved products to address the critical unmet needs of patients. For instance, in April 2020, Strides Pharma Global Pte. Limited, a subsidiary of Strides Pharma Science Limited, received approval from the U.S. Food and Drug Administration (FDA) for Flucytosine Capsules USP, 250 mg and 500 mg.

Moreover, government initiatives is expected to facilitate the market growth. For instance, the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional drug regulators control and regulate clinical trial registration, approval, and assessment of drugs, and other treatments for vaginal fungi infection. Moreover, vaginal fungi infection can be treated with off label drugs such as miconazole topical and Gyne-Lotrimin. In key regions such as North America, there is no regulatory or legal authority to regulate the use of such off-label drugs.

However, alternative therapies for vaginal fungi infections treatment can hinder the market growth. For instance, Peachlife, a women led company, which offers menstrual cup and probiotic vaginal suppositories, offers Peachlife Probiotic + Aloe Vera Vaginal Suppositories and Peachlife Boric Acid vaginal suppositories. These suppositories are finely milled boric acid to prevent yeast infections, bacterial vaginosis, candida and urinary tract infections (UTI), odor, itching & discharge.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4271

Key Market Takeaways:

The global vaginal fungi infections treatment market is expected to exhibit a CAGR of 5.3% during the forecast period, owing to rising incidence of vaginal fungi infection. For instance, according to The Lancet, in August 2018, the prevalence of recurrent vulvovaginal candidiasis per 100,000 females in Brazil were 4,223 and in Mexico were 4,100.

Key players in the market are focused on collaborations and partnerships to enhance their product portfolio which is expected to propel the market growth during the forecast period. For instance, in March 2018, Hikma Pharmaceuticals PLC entered into a 4-year global partnership with a medical relief organization, Direct Relief, to increase the availability and accessibility of Hikma’s products.

Competitive Landscape:

Key players operating in the global vaginal fungi infections treatment market include Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC medical AB, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, and SCYNEXIS, Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4271

Market Segmentation:

• Global Vaginal Fungi Infections Treatment Market, By Drug Type:
  • Fluconazole
  • Nystatin
  • Flucytosine
  • Others
• Global Vaginal Fungi Infections Treatment Market, By Route of Administration:
  • Oral
  • Topical
• Global Vaginal Fungi Infections Treatment Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Vaginal Fungi Infections Treatment Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.